NIDA NATIONAL PREVENTION RESEARCH INITIATIVE (NNPRI):  COMMUNITY MULTI-SITE 
PREVENTION TRIALS (CMPT), RFA-DA-02-004 and TRANSDISCIPLINARY PREVENTION 
RESEARCH CENTERS, RFA-DA-02-005 and USING BASIC SCIENCE TO DEVELOP NEW 
DIRECTIONS IN DRUG ABUSE PREVENTION RESEARCH, RFA-DA-02-010

Release Date:  February 5, 2002

NOTICE:  NOT-DA-02-002

National Institute on Drug Abuse (NIDA)
 (http://www.nida.nih.gov)

PURPOSE

Prevention of drug abuse and HIV/AIDS is an area of interest in the 
three components of NIDA's National Prevention Research Initiative:  1) 
Community Multi-site Prevention Trials, DA-02-004; 2) Transdisciplinary 
Prevention Research Centers, DA-02-005 (both RFAs were published 
January 4, 2002 in the NIH Guide); and 3) Using Basic Science To 
Develop New Directions In Drug Abuse Prevention Research, DA-02-010 
(this RFA was published December 17, 2001 in the NIH Guide).  The 
Initiative invites drug use-related HIV/AIDS prevention applications 
that focus on interventions for children, adolescents, and young adults 
at different levels of drug use and risk.  Special populations of 
interest include youth with co-morbid mental health problems, homeless 
youth, youth experiencing academic failure or who have dropped out of 
school, youth diagnosed as HIV positive, and youth in foster care. 
Applications may include interventions delivered in diverse contexts, 
such as schools, primary health care, juvenile justice facilities, 
mental health facilities, religious organizations, community 
organizations, etc. 

INQUIRIES:  

o Direct questions for RFA-DA-02-004 to:

Elizabeth Robertson, Ph.D.
Chief, Prevention Research Branch
Division of Epidemiology, Services, and Prevention Research
National Institute on Drug Abuse
6001 Executive Boulevard, MSC 9589
Bethesda, MD  20892-9589
Telephone:  (301) 443-1514
FAX:  (301) 443-2636
Email:  er52h@nih.gov or

S. Jackie Kaftarian, Ph.D.
Prevention Research Branch
Division of Epidemiology, Services, and Prevention Research
National Institute on Drug Abuse
6001 Executive Boulevard, MSC 9589
Bethesda, MD  20892-9589
Telephone:  (301) 443-1514
FAX:  (301) 443-2636
Email:  jkaftari@nida.nih.gov

o Direct questions for RFA-DA-02-005 to:  

Minda Lynch, Ph.D.
Division of Neuroscience and Behavioral Research
National Institute on Drug Abuse
6001 Executive Boulevard
Bethesda, MD  20892-9547
Telephone:  (301) 443-1887
FAX:  (301) 594-6043
Email:  mlynch@nida.nih.gov

Eve Reider, Ph.D.
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse
6001 Executive Boulevard
Bethesda, MD  20892-9589
Telephone:  (301) 443-1514
FAX:  (301) 443-2636
Email:  ereider@mail.nih.gov

o Direct questions for RFA-DA-02-010 to:  

David Shurtleff, Ph.D.
Division of Neuroscience and Behavioral Research
National Institute on Drug Abuse
6001 Executive Boulevard, Room 4282, MSC 9555
Bethesda, MD  20892-9555
Telephone:  (301) 443-1887
FAX:  (301) 594-6043
Email:  dshurtle@mail.nih.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.